What is the current market price of generic regorafenib?
Regorafenib (Regorafenib) is a multi-target small molecule targeted drug, mainly used to treat various malignant tumors such as advanced intestinal cancer and liver cancer. It inhibits tumor cell proliferation and angiogenesis by inhibiting multiple signaling pathways, thereby inhibiting tumor growth and metastasis. In China, regorafenib has been launched and included in the medical insurance system, and patients can purchase the drug through hospitals. However, the price of original drugs is relatively high, and many patients choose to purchase relatively cheaper generic drugs.
in the country, regorafenib has been included in medical insurance and can be partially reimbursed through medical insurance. The specific drug prices may vary in different regions and hospitals, but the general price range is around RMB 4,000 to RMB 5,000. Because regorafenib is an imported drug and is relatively expensive, many patients want to know if there are more affordable options. Generic drugs have undoubtedly become a more attractive option for patients who need to take the drug long-term.
The original drug of regorafenib is currently mainly produced by Turkish pharmaceutical companies in foreign markets, and the drug has relatively stable sales in the international market. The price of the original drug is relatively high, and the price in the Turkish market is about more than 1,000 yuan. However, due to factors such as import tariffs and transportation costs, the price of original drugs in the country will usually rise further. Therefore, many patients choose to purchase relatively cheap generic drugs in order to reduce treatment costs.
Currently, generic drugs of regorafenib mainly come from countries such as Laos, India, and Bangladesh, and the prices of these generic drugs are relatively affordable. Taking generic drugs in Laos and India as an example, the price ranges from a few hundred yuan to more than a thousand yuan. Although the price is significantly lower than that of the brand-name drugs, the pharmaceutical ingredients of these generic drugs are basically the same as those of the brand-name drugs and they have undergone strict quality control, so they are considered to be alternatives with the same therapeutic effect. Many patients choose generic drugs not only because they are cheaper, but also because their efficacy and safety have been proven in multiple clinical studies.
Reference materials:https://www.stivarga-us.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)